[1] Amit M, Yen T, Liao C, et al.Improvement in survival of patients with oral cavity squamous cell carcinoma: an international collaborative study[J]. Cancer, 2013,119(24): 4242-4248. [2] Sakamoto Y, Matsushita Y, Yamada SI, et al.Risk factors of distant metastasis in patients with squamous cell carcinoma of the oral cavity[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2015, 121(5): 474-480. [3] Brouns E, Baart J, Bloemena E, et al.The relevance of uniform reporting in oral leukoplakia: definition, certainty factor and staging based on experience with 275 patients[J]. Med Oral Patol Oral Cir Bucal, 2012, 18(1): e19-e26. [4] Liu Y, Li Y, Fu Y, et al.Quantitative prediction of oral cancer risk in patients with oral leukoplakia[J]. Oncotarget, 2017, 8(28): 46057-46064. [5] 王宇峰, 尚书, 周曾同, 等. 口腔白斑癌变率与癌变时间及其影响因素的回顾分析[J]. 上海口腔医学, 2011, 20(1): 65-71. [6] Kim SJ, Kim SH, Kim JH, et al.Understanding metabolomics in biomedical research[J]. Endocrinol Metab, 2015, 31(1): 7-16. [7] Gupta A, Gupta S, Mahdi A, et al.1H NMR-derived serum metabolomics of leukoplakia and squamous cell carcinoma[J]. Clin Chim Acta, 2015, 441(1): 47-55. [8] Ohshima M, Sugahara K, Kasahara K, et al.Metabolomic analysis of the saliva of Japanese patients with oral squamous cell carcinoma[J]. Oncol Rep, 2017, 37(5): 2727-2734. [9] Navazesh M.Methods for collecting saliva[J]. Ann N Y Acad Sci, 1993, 694(1):72-77. [10] Martínez-Arranz, Ibon, Mayo R, Pérez-Cormenzana M, et al. Enhancing metabolomics research through data mining[J]. J Proteomics, 2015,127(Pt B): 275-288. [11] Lubes G, Goodarzi M.GC-MS based metabolomics used for the identification of cancer volatile organic compounds as biomarkers[J]. J Pharm Biomed Anal, 2018, 147: 313-322. [12] Wang Q, Yu Q, Lin Q, et al.Emerging salivary biomarkers by mass spectrometry[J]. Clin Chim Acta, 2015, 438: 214-221. [13] Koneru S, Tanikonda R.Salivaomics - a promising future in early diagnosis of dental diseases[J]. Dent Res J, 2014, 11(1): 11-15. [14] Schwartz L, Supuran CT, Alfarouk KO.The warburg effect and the hallmarks of cancer[J]. Anticancer Agents Med Chem, 2017, 17(2): 164-170. [15] Hui S, Ghergurovich JM, Morscher RJ, et al.Glucose feeds the TCA cycle via circulating lactate[J]. Nature, 2017, 551(7678): 115-118. [16] Olsson B, Cox TF, Psarelli EE, et al.Relationship between serum concentrations of nitisinone and its effect on homogentisic acid and tyrosine in patients with alkaptonuria[J]. JIMD Rep, 2015, 24(1):21-27. [17] Hussain SP, Harris CC.Inflammation and cancer: an ancient link with novel potentials[J]. Int J Cancer, 2007, 121(11): 2373-2380. [18] Sheng H, Shao J, Washington MK, et al.Prostaglandin E2 increases growth and motility of colorectal carcinoma cells[J]. J Biological Chem, 2001, 276(21): 18075-18081. |